Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization

RT @FrontOncology: New research: Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor ra…

New research: Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization: Polyadenosine diphosphate-ribose polymerase (PARP) is a key modifying enzyme in cells, which… https://t.co/kUn